Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
The Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and Hydrocephalus.
A nurse-led mental health service for people with multiple sclerosis.
Early detection of MS treatment complication may improve survival
Tenascins and inflammation in disorders of the nervous system.
Life-threatening asthma attack during prolonged fingolimod treatment: case report.
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
Atypical forms of optic neuritis.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Melanocortins as Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives.
The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35-55-Induced Experimental Autoimmune Encephalomyelitis.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
T-bet or not T-bet: Taking the last bow on the autoimmunity stage.
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Feedforward postural control in individuals with multiple sclerosis during load release.
The nervous system's potential role in multiple sclerosis associated bone loss.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »